Document is current
Any future updates will be listed below
-
Authors
Balata, Mahmoud
Becher, Marc Ulrich
-
Funding
Funding for this research was provided by:
Universitätsklinikum Bonn
- License Information
-
More Information
Article History
Received: 4 February 2024
Accepted: 21 October 2024
First Online: 26 October 2024
Declarations
:
: This retrospective study was reviewed and approved by the Ethics Committee at the University of Bonn (reference number 266/22). Informed consent for the off-label use of semaglutide in treating obesity was obtained from all non-diabetic individuals, or their legal guardians. Our research strictly adhered to relevant guidelines and regulations throughout the entire process.
: The authors declare no competing interests.
: Not applicable.
: Not applicable.
